• Mission & Focus
• Organisational Structure
• Centre Funding
• Board Charters
• ASCC Research Services
• Work & Study opportunities
• Partnerships
• International Stem Cell Initiatives

The Australian Stem Cell Centre has established and continues to seek partnerships with leaders in research and industry who will contribute to the Centre's goal of delivering stem cell therapies to patients.

Academic Partners

The Australian Stem Cell Centre is comprised of a number of universities and research institutes representing Australia's leading stem cell research scientists.

Stakeholders
In July 2003, seven "Stakeholder" universities and research institutes entered into an agreement with ASCC Ltd which governs the interaction of parties, treatment of intellectual property and sharing of commercial benefits. The founding Stakeholders are:

• University of Adelaide
• Monash University
• University of Queensland
• Howard Florey Institute
• Peter MacCallum Cancer Institute
• Victor Chang Cardiac Research Institute

Additional Stakeholders include:

• Murdoch Childrens Research Institute
• Baker Heart Research Institute
• Mater Medical Research Institute

The nature and extent of each Stakeholders' research participation in the Centre will depend upon the outcome of the due diligence process. Over time it is expected that further universities and research institutes will join the Centre and contribute to its activities.

Commercial Partners

It is anticipated that the Centre will enter into a number of collaborative arrangements with commercial partners in order to access certain technologies for use by the Centre's research scientists.

The ASCC has a number of collaborative agreements with industry to advance specific aspects of stem cell research. These are with:

• Singapore-based ES Cell International Pte Ltd (ESI), for commercialisation of research outcomes at Monash University relevant to diabetes;
• US-based company LifeCell Corp, to collaborate in the area of tissue repair. This includes a licence to use their proprietary acellular matrix technology in ASCC programs, and the ability to collaborate in future development for products incorporating both LifeCell and ASCC technology.
• Millipore Corporation, a major international research reagent company for the commercialisation and distribution of research reagents developed by the ASCC. This relationship ensures that the global scientific community are able to access ASCC technologies that facilitate stem cell research including cell lines, recombinant proteins, antibodies and novel kits.

Page Top